title: Commentary: reduction of type II endoleak using embolization of the aneurysm sac during EVAR.
authors.affiliation: Sections of Vascular Surgery and Interventional Radiology, Yale University School of Medicine, New Haven, Connecticut, USA. frederik.jonker@yale.edu
authors.forename: Frederik H W
authors.initials: FH
authors.lastname: Jonker
authors.forename: John
authors.initials: J
authors.lastname: Aruny
authors.forename: Frans L
authors.initials: FL
authors.lastname: Moll
authors.forename: Bart E
authors.initials: BE
authors.lastname: Muhs
mesh_terms: D017544:Aortic Aneurysm, Abdominal / Q000601:surgery / Q000628:therapy*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation*; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic / Q000295:instrumentation; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D011474:Prosthesis Design; D011475:Prosthesis Failure; D018570:Risk Assessment; D012307:Risk Factors; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015718:Fibrin Tissue Adhesive